别名 CysLT(2)、CYSLT2、CYSLT2R + [6] |
简介 Receptor for cysteinyl leukotrienes. The response is mediated via a G-protein that activates a phosphatidylinositol-calcium second messenger system. Stimulation by BAY u9773, a partial agonist, induces specific contractions of pulmonary veins and might also have an indirect role in the relaxation of the pulmonary vascular endothelium. The rank order of affinities for the leukotrienes is LTC4 = LTD4 >> LTE4. |
作用机制 CysLT1拮抗剂 [+1] |
在研适应症- |
非在研适应症- |
最高研发阶段药物发现 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 CysLT1拮抗剂 [+1] |
在研机构- |
在研适应症- |
最高研发阶段无进展 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2015-01-14 |
申办/合作机构 |
开始日期2015-01-01 |
申办/合作机构 |
开始日期2012-06-01 |
申办/合作机构 Ono Pharma USA, Inc. [+1] |